BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 16855788)

  • 21. ARF tumor suppression in the nucleolus.
    Maggi LB; Winkeler CL; Miceli AP; Apicelli AJ; Brady SN; Kuchenreuther MJ; Weber JD
    Biochim Biophys Acta; 2014 Jun; 1842(6):831-9. PubMed ID: 24525025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
    Kurki S; Peltonen K; Latonen L; Kiviharju TM; Ojala PM; Meek D; Laiho M
    Cancer Cell; 2004 May; 5(5):465-75. PubMed ID: 15144954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.
    Bertwistle D; Sugimoto M; Sherr CJ
    Mol Cell Biol; 2004 Feb; 24(3):985-96. PubMed ID: 14729947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of p53 by p14ARF without relocation of MDM2 to the nucleolus.
    Llanos S; Clark PA; Rowe J; Peters G
    Nat Cell Biol; 2001 May; 3(5):445-52. PubMed ID: 11331871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleolar protein GLTSCR2 stabilizes p53 in response to ribosomal stresses.
    Lee S; Kim JY; Kim YJ; Seok KO; Kim JH; Chang YJ; Kang HY; Park JH
    Cell Death Differ; 2012 Oct; 19(10):1613-22. PubMed ID: 22522597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization.
    Kurki S; Latonen L; Laiho M
    J Cell Sci; 2003 Oct; 116(Pt 19):3917-25. PubMed ID: 12915590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRMT1 promotes the tumor suppressor function of p14
    Repenning A; Happel D; Bouchard C; Meixner M; Verel-Yilmaz Y; Raifer H; Holembowski L; Krause E; Kremmer E; Feederle R; Keber CU; Lohoff M; Slater EP; Bartsch DK; Bauer UM
    EMBO J; 2021 Jul; 40(13):e106777. PubMed ID: 33999432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.
    Weber JD; Kuo ML; Bothner B; DiGiammarino EL; Kriwacki RW; Roussel MF; Sherr CJ
    Mol Cell Biol; 2000 Apr; 20(7):2517-28. PubMed ID: 10713175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.
    Zhang Y; Xiong Y
    Mol Cell; 1999 May; 3(5):579-91. PubMed ID: 10360174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ARF in the mitochondria: the last frontier?
    Itahana K; Clegg HV; Zhang Y
    Cell Cycle; 2008 Dec; 7(23):3641-6. PubMed ID: 19033735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway.
    Yogev O; Saadon K; Anzi S; Inoue K; Shaulian E
    Cancer Res; 2008 Mar; 68(5):1398-406. PubMed ID: 18316603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT7-dependent deacetylation of NPM promotes p53 stabilization following UV-induced genotoxic stress.
    Ianni A; Kumari P; Tarighi S; Simonet NG; Popescu D; Guenther S; Hölper S; Schmidt A; Smolka C; Yue S; Krüger M; Fiorillo C; Vaquero A; Bober E; Braun T
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA.
    Kawagishi H; Nakamura H; Maruyama M; Mizutani S; Sugimoto K; Takagi M; Sugimoto M
    Cancer Res; 2010 Jun; 70(11):4749-58. PubMed ID: 20501856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation.
    Ayrault O; Andrique L; Fauvin D; Eymin B; Gazzeri S; Séité P
    Oncogene; 2006 Dec; 25(58):7577-86. PubMed ID: 16924243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of nucleolar versus non-nucleolar forms of human p14(ARF).
    Rodway H; Llanos S; Rowe J; Peters G
    Oncogene; 2004 Aug; 23(37):6186-92. PubMed ID: 15286709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.
    Rizos H; Darmanian AP; Mann GJ; Kefford RF
    Oncogene; 2000 Jun; 19(26):2978-85. PubMed ID: 10871849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Essential role of the B23/NPM core domain in regulating ARF binding and B23 stability.
    Enomoto T; Lindström MS; Jin A; Ke H; Zhang Y
    J Biol Chem; 2006 Jul; 281(27):18463-72. PubMed ID: 16679321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.